Page last updated: 2024-11-05

troglitazone and HIV Coinfection

troglitazone has been researched along with HIV Coinfection in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"Treatment with troglitazone 400 mg q."6.69Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. ( Brinkmann, L; Goebel, FD; Michl, GM; Mühlbayer, D; Walli, R, 2000)
"Treatment with troglitazone 400 mg q."2.69Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. ( Brinkmann, L; Goebel, FD; Michl, GM; Mühlbayer, D; Walli, R, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walli, R1
Michl, GM1
Mühlbayer, D1
Brinkmann, L1
Goebel, FD1

Trials

1 trial available for troglitazone and HIV Coinfection

ArticleYear
Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 2000, Volume: 199, Issue:5

    Topics: Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Body Weight; Chromans; Diabetes Mellitus; HIV

2000